Advantages
Proprietary, high-throughput technologies simultaneously deliver many different antibody preparations, each with a different specificity. This is ideal for customers seeking antibody content for their antibody arrays and protein arrays. All of your antibodies can be obtained from one source and delivered to you in one shipment.
You can start immunizing sooner! Production and purification of protein antigen is not required to start immunization. Protein expression, purification, characterization, storage and shipment of protein are eliminated. Problems with difficult proteins are avoided. Antigen lot-to-lot variability is eliminated. Peptide synthesis is not required to start immunization.
Antibodies can be directed to a region of the protein antigen, such as to the ligand binding site of a receptor. They can also be directed to the active site of an enzyme, or to a common epitope in a protein family, or to a unique epitope of one of these family members. Matched pairs of antibodies can be developed.
You can order Genomic Antibody Technology™ online by submitting your genetic sequence using your STAR Account. You can use a purchase order or your credit card to order online today.
Sign in to your STAR Account, or register to create one.
NOVUS BIOLOGICALS and SDIX™ Form Exclusive Partnership to Create and Disseminate Premade GAT™ Antibodies
more
SDI Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for use in Cancer Research.
more
SDI to Produce Library of Antibodies for the Study of Usher Syndrome.
more
SDI Enters Supply Agreement for Antibody Library for Study of Chromosome Proteins with University of North Carolina Chapel Hill
more
SDI Announces Progress in Advancing Clinical Biomarker Discovery, Successful Application of Technology in Cancer Biomarker Identification at M.D. Anderson Cancer Center
more
Strategic Diagnostics Inc. Announces Partnership with the University of Delaware and the Helen F. Graham Cancer Center to Develop Cancer Assays
more
SDI Announces Success in Demonstrating Utility of its Proprietary Genomic Antibody Technology™ Reagents on Clinical Samples in Cooperation with the Human Protein Atlas
more